Arkolith/Insider Trading/VCEL/Form 4

Hopper Jonathan Mark

Chief Medical OfficerVericel Corp (VCEL) · full profile →Form 4 · filed Apr 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$122K
Net Open-Market Flow
-$122K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)3K$10.95$38K79K
Apr 2, 2026Sell(S)3K$35.00$122K76K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)3K—$09K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-013334) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML